Vaccinex, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
Vaccinex, Inc. (VCNX) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price of $3129.00 per share for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice · last filed 2025-04-15
- Vaccinex, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2024-03-31 was $3129.00, a 20900.00% increase year-over-year.
- Vaccinex, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2023-03-31 was $14.90.
- Vaccinex, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2024 was $3129.00, a 0.00% change from fiscal 2023.
- Vaccinex, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2023 was $3129.00.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2024-12-31 | $3129.00 10-K · filed 2025-04-15 | |||
| 2024-09-30 | $3129.00 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | $3129.00 10-Q · filed 2024-08-14 | |||
| 2024-03-31 | $3129.00 10-Q · filed 2024-05-15 | |||
| 2023-12-31 | $3129.00 10-K · filed 2025-04-15 | |||
| 2023-09-30 | $223.60 10-Q · filed 2023-11-13 | |||
| 2023-06-30 | $14.90 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | $14.90 10-Q · filed 2023-05-15 |